Drug pricing concerns? Not at Gilead
January 05, 2015 at 10:41 AM EST
After drug pricing concerns weighed on Gilead Sciences' stock toward the end of December, the drugmaker has kicked off 2015 the same way it did the previous two years: by increasing prices.